Drug Type Chemical drugs |
Synonyms- |
Target |
Action inhibitors |
Mechanism DprE1 inhibitors(FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Tuberculosis | IND Approval | China | 12 Nov 2024 | |
Tuberculosis | IND Approval | China | 12 Nov 2024 | |
Pulmonary Tuberculosis | Preclinical | China | 26 Dec 2023 |